MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/medicina62030540

Медицинская библиотека · Medicina (Kaunas, Lithuania) · 2026

Myocardial Viability and Ischaemia in Chronic Total Occlusion.

Mehmood Zia, Suresh Preethi, Li Rui, Assadi Hosamadin, Kasmai Bahman, Thampi Kurian, Maart Clint, Gilbert Timothy, Eccleshall Simon, Sawh Chris, Nair Sunil, van der Geest Rob J, Vassiliou Vassilios S, Ryding Alisdair, Matthews Gareth, Garg Pankaj

СтатьяПеревод пока не подготовлен

Аннотация

Background and

Objectives

Chronic total occlusion (CTO) affects 30% of patients undergoing coronary angiography rendering poorer outcomes. While percutaneous coronary intervention (PCI) can be technically successful, RCTs show no survival benefit. Cardiovascular Magnetic Resonance (CMR) provides comprehensive myocardial phenotyping, offering prognostic insights in this high-risk cohort. Materials and

Methods

Fifty-six patients with angiographically confirmed CTO underwent stress perfusion CMR with late gadolinium enhancement. Myocardial function, ischaemia and scar burden were quantified and compared across CTO territory and viability subgroups.

Results

In patients with CTO, 27% of patients (15/56) had no viability. In patients with viable myocardium, 66% (27/41) demonstrated reversible ischaemia. Viable myocardium was associated with significantly higher LV stroke volumes (93.6 ± 20.1 mL vs. 80.9 ± 18.4 mL, p = 0.039), along with lower LV scar mass (18.7 ± 13.5g vs. 32.3 ± 12.8g; p = 0.002) and scar percentage (14.9 ± 8.3% vs. 25.9 ± 7.5%; p = 0.001). Viable myocardium showed more ischaemia both globally (11.6 ± 14.3g vs. 0.2 ± 9.3g; p = 0.005) and within the CTO territory (10.3 ± 10.3% vs. 2.3 ± 2.7%; p = 0.01). Non-viable myocardium was associated with significantly higher CTO-territory scar mass (9.4 ± 6.5 g vs. 5.1 ± 6.9 g; p = 0.046) and scar percentage (21.8 ± 13.3% vs. 11.7 ± 12.8%; p = 0.01), indicating extensive fibrosis. A scar burden threshold of 11.18% in CTO territory predicted non-viability with 80% sensitivity and 65.85% specificity (AUC = 0.701 [95% CI 0.54-0.87], p = 0.019).

Conclusions

Among CTO patients, 27% harbour no viability, while patients with viable myocardium typically exhibit reversible ischaemia-representing a phenotype with preserved viability and inducible ischaemia. These findings support the use of multiparametric CMR to phenotype CTO territories prior to considering CTO-PCI.

Для цитирования: Mehmood Zia, Suresh Preethi, Li Rui, Assadi Hosamadin, Kasmai Bahman, Thampi Kurian, Maart Clint, Gilbert Timothy, Eccleshall Simon, Sawh Chris, Nair Sunil, van der Geest Rob J, Vassiliou Vassilios S, Ryding Alisdair, Matthews Gareth, Garg Pankaj. Myocardial Viability and Ischaemia in Chronic Total Occlusion.. Medicina (Kaunas, Lithuania). 2026. DOI: 10.3390/medicina62030540.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.